Press Releases

 Filter by Provider

Sturm, Ruger & Company, Inc. (NYSE: RGR) (“Ruger” or the “Company”) today announced, in connection with the Board refreshment process initiated several years ago, the appointment of Aaron Rivers, Stephen Timm and Lorin Cassidy Wolfe to the Company’s Board of Directors (the “Board”). Concurrently, Sandra Froman, Christopher Killoy and Rebecca Halstead have retired from the Board. In addition, as previously disclosed, Ronald Whitaker does not plan to stand for reelection at the Company’s 2026 annual meeting.

Enhabit, Inc. (NYSE: EHAB), a leading national home health and hospice provider, today announced it has entered into a definitive agreement to be acquired by Kinderhook Industries, LLC (“Kinderhook”), a middle market private equity firm, in an all-cash transaction for a total enterprise value of approximately $1.1 billion.

Service Properties Trust (Nasdaq: SVC) today announced that its wholly owned subsidiaries, SVC ABS LLC, SVC 2026 ABS LLC and SVC 2026 TA ABS LLC, acting as co-issuers, have priced $745 million in principal amount of net lease mortgage notes in a transaction exempt from registration from the Securities Act of 1933, as amended, or the Securities Act, and sold to Qualified Institutional Buyers as defined in Rule 144A under the Securities Act and in offshore transactions to non-U.S. persons outside the U.S. in accordance with Regulation S under the Securities Act. This transaction is expected to close on March 6, 2026, subject to the satisfaction of customary closing conditions. The notes will be issued in three classes to institutional buyers in the following principal amounts, and are expected to be rated by Standard & Poor’s Ratings Services as follows:

KnowBe4, the world-renowned platform that comprehensively addresses human and agentic AI risk management, today announced the opening of a new office in Arlington, Virginia, expanding its footprint in the Washington, D.C., Maryland and Virginia (DMV) region. The new location underscores KnowBe4’s continued investment in the public sector and its commitment to helping organizations address human risk management, AI-enabled threats and evolving national security challenges.

Venu Holding Corporation ("VENU" or the "Company") (NYSE American: VENU), owner, operator, and developer of premium entertainment and hospitality destinations, announced today that the structural framework of the stunning 134,000 sqft canopy roof has been installed on the Sunset Amphitheater at Broken Arrow, powered by EIGHT Elite Light Beer. With the primary structure now in place, the 12,500-capacity venue is one step closer to opening its doors for its inaugural concert season targeted for Fall 2026.

Immunome, Inc. (Nasdaq: IMNM), a biotechnology company focused on developing first-in-class and best-in-class targeted cancer therapies, today announced that members of Immunome’s management will present at the following investor conferences:

Prime Capital Financial expands in the Mid-Atlantic region by adding Joan Greenspon, CFP®, a Philadelphia-area financial advisor with more than a decade of experience supporting families through major life transitions.

Culp, Inc., a leading provider of fabrics for bedding and upholstery fabrics for residential, commercial, and hospitality furniture and other applications, today announced it will voluntarily transfer its stock exchange listing from the New York Stock Exchange to the Nasdaq Capital Market (“Nasdaq”). CULP’s common stock is expected to begin trading as a Nasdaq-listed security at market open on March 6, 2026, under its existing “CULP” stock symbol.

Actuaries spend a substantial amount of their time searching for information buried in technical documentation on risk modeling. Global financial technology leader FIS® is changing that today with the launch of its Insurance Risk Suite AI Assistant, a generative AI tool that instantly answers complex questions about building and maintaining risk models—in any language.

Momentus Inc. (NASDAQ: MNTS), a U.S. commercial space company specializing in satellite technology, space transportation, and orbital services, announced today that the Company has delivered its Vigoride Orbital Service Vehicle (OSV) to Vandenberg Space Force Base in California ahead of its launch on SpaceX’s upcoming Transporter‑16 rideshare mission, targeted for no earlier than late March 2026.

Prime Capital Financial announces the addition of Amanda Salyer, CFP®, a seasoned financial advisor focused on comprehensive, goals-based planning for individuals and families.

There were an estimated 44% more home sellers than buyers in the U.S. housing market in January (or 600,314 more, in numerical terms), according to a new report from Redfin, the real estate brokerage powered by Rocket. That’s up from 30% more a year earlier and represents the second largest gap in records dating back to 2013. The largest gap was in December 2025, when sellers outnumbered buyers by 45%.

Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr virus (EBV) T-cell platform to develop transformative therapies for patients with cancer and autoimmune diseases, today announced that the Company entered into an amendment (the Amendment) to the Purchase and Sale Agreement dated as of December 20, 2022 with a fund managed by HealthCare Royalty (“HCRx”). Under the terms of the Amendment, HCRx agreed to amend the due date of the one-time of $9.0 million cash payment associated with the achievement of a certain milestone within the Amended and Restated Commercialization Agreement dated October 31, 2023, with Pierre Fabre Medicament, as amended, from June 30, 2026 to January 1, 2028.

HealthTrust Performance Group™ (HealthTrust) a leading healthcare performance improvement organization, today announced that Jocelyn Bradshaw, Chief Operating Officer of GPO Operations, has been promoted to President of GPO Operations. In this new role, Bradshaw will assume responsibility for all strategy and execution of daily operations for the Group Purchasing Organization (GPO).

Treasure Data today announced the general availability of Treasure Code, an AI-native command-line interface transforming how teams operate the Treasure Data Intelligent Customer Data Platform (CDP). Treasure Code enables technical teams and AI agents to securely operate the entire Treasure Data platform as code, bringing DevOps discipline and automation to every part of the CDP.

Scale, a leading vertically integrated provider of advanced energy solutions, is pleased to announce the acquisition of Reload, a platform that sites, designs, and permits gigawatt-scale data center campuses paired with rapidly deployable on-site power infrastructure.

Nile, an industry leader for secure, autonomous Network-as-a-Service (NaaS), today announced the appointment of Frank Wiacek as Chief Revenue Officer (CRO), reporting to Nile CEO Pankaj Patel. In this role, Wiacek will lead Nile’s global revenue organization, overseeing sales, partnerships, and go-to-market execution as the company accelerates growth of its secure Network-as-a-Service (NaaS) solutions.

Today, IHOP is establishing an ownable, brand-defining moment by declaring the first Tuesday of March as National Pancake Day. To officially kick off this annual tradition, IHOP will celebrate National Pancake Day on Tuesday, March 3 by inviting guests to “meet up” at participating IHOP locations nationwide and enjoy a free Short Stack of buttermilk pancakes from 7am to 8pm.

Eldridge Capital Management (“Eldridge”) today announced the closing of a $350 million lease facility with ProPetro Energy Solutions, LLC d/b/a PROPWRSM (“PROPWR”), a wholly owned subsidiary of ProPetro Holding Corp. (NYSE: PUMP). The facility will provide PROPWR, the power generation solutions division of ProPetro, with access to growth capital for the acquisition of new power generation equipment for its robust and growing commercial pipeline across oilfield, industrial, and datacenter sectors.

Synthekine Inc., an engineered cytokine therapeutics company, today announced the appointment of John A. Orwin as Chair of its Board of Directors. Mr. Orwin succeeds Srinivas Akkaraju, M.D., Ph.D., Founder and Managing General Partner at Samsara BioCapital, who has served as Chair since the company’s early days and will continue to serve as an active member of the Board.

It’s back! Applebee’s is once again bringing the bold flavors of New Orleans to neighborhoods nationwide with the return of its Big Easy Menu starting at $11.99.* Now for a limited time, guests can enjoy the bold flavor of the Bayou for an unbeatable price with two new Cajun-inspired dishes, the NEW Big Easy Burger and NEW Bayou Shrimp Bowl. Plus, Applebee’s savory Bourbon Street Chicken & Andouille Sausage Penne, starting at $11.99, is available for a limited time!

Farmers & Merchants Bank of Long Beach (OTCQX: FMBL) today announced that its board of directors has approved the Bank’s regular quarterly cash dividend of $28 per share on the Bank’s common and preferred stock.

Viant Technology Inc. (Nasdaq: DSP), a leader in CTV and AI-powered programmatic advertising, today announced that members of its management team are scheduled to participate in upcoming investor conferences.

ACORE CAPITAL, one of the leading U.S. commercial real estate investment managers, today announced the closing of ACORE 2026-FL1, a $1.1 billion managed commercial real estate collateralized loan obligation (CRE CLO). The CRE CLO’s initial collateral pool consists of 22 loans secured primarily by multifamily and industrial properties. The sponsor of the transaction is ACORE Credit Partners II REIT, Inc.

Armis, the cyber exposure management & security company, today announced that it has achieved authorization from the U.S. DoD’s Defense Information Systems Agency (DISA) to operate at an Impact Level 5 (IL5). This means that Armis has met strict requirements to manage and secure the DoD’s critical infrastructure, including Controlled Unclassified Information (CUI) systems.

For more than three decades, Integrated DNA Technologies (IDT) has helped power the genomics revolution, enabling scientists to decode biology with growing precision and speed. Today, as cancer research enters a new era defined by ultra‑sensitive identification and rapidly expanding biomarker landscapes, IDT is announcing a suite of next generation sequencing (NGS) innovations that aim to tackle longstanding bottlenecks in library preparation, targeted enrichment, and whole genome analysis.

PulteGroup, Inc. (NYSE: PHM) today announced that it will release its first quarter 2026 financial results before the market opens on Thursday, April 23, 2026. The Company will hold a conference call to discuss its first quarter results that same day at 8:30 a.m. (ET).

The new brand unifies multiple agencies into a single strategic communications firm focused on advancing client needs in the nation’s most essential infrastructure sectors

BOULDER, Colo., Feb. 23, 2026 (GLOBE NEWSWIRE) -- VFN Holdings, Inc. (“Vero Networks, or Vero”), a leading fiber infrastructure business and broadband internet provider, today announced the successful closing of a $500 million non-control growth equity investment. The investment was led by funds managed by Hamilton Lane (Nasdaq: HLNE), Braemont Capital and Delta-v Capital (together, the “Investor Group”).

Forescout Technologies, a global leader in cybersecurity, today announced its partnership with the Electricity Information Sharing and Analysis Center (E-ISAC), a division of the North American Electric Reliability Corporation (NERC), as a Vendor Affiliate Program Partner. Under the new partnership, Forescout will deliver Forescout Research – Vedere Labs intelligence to the E-ISAC community and engage with utilities and government leaders on evolving cyber and physical threats.

IRVINE, Calif., Feb. 23, 2026 (GLOBE NEWSWIRE) -- CG Oncology, Inc. (NASDAQ: CGON) today announced that Arthur Kuan, Chairman & Chief Executive Officer, and Ambaw Bellete, President & Chief Operating Officer, will present at the TD Cowen 46th Annual Health Care Conference on Monday, March 2, 2026, at 3:10 pm ET. The conference is taking place at the Boston Marriott Copley Place in Boston, MA.

ROCKVILLE, Md. and SUZHOU, China, Feb. 23, 2026 (GLOBE NEWSWIRE) -- Ascentage Pharma Group International (NASDAQ: AAPG; HKEX: 6855) (“Ascentage Pharma” or the “Company”), a global, commercial stage, integrated biopharmaceutical company engaged in the discovery, development and commercialization of novel, differentiated therapies to address unmet medical needs in cancer, announced today that the Company's management is scheduled to participate in three upcoming investor conferences.

BOSTON, Feb. 23, 2026 (GLOBE NEWSWIRE) -- Boston Legacy FC today announced a multi-year partnership with Collegium Pharmaceutical, an emerging biopharmaceutical leader in the Boston area, naming the company an Official Partner of Boston Legacy FC. Through this collaboration, Boston Legacy FC and Collegium are working together to ensure that the club’s home games are welcoming and sensory-inclusive for all fans.

WEST CHESTER, Pa., Feb. 23, 2026 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. (“Verrica”) (Nasdaq: VRCA), a dermatology therapeutics company developing and selling medications for skin diseases requiring medical interventions, today announced that Jayson Rieger, PhD, MBA, President and Chief Executive Officer of Verrica Pharmaceuticals, will present at the TD Cowen 46th Annual Healthcare Conference in Boston.

SAN DIEGO, Feb. 23, 2026 (GLOBE NEWSWIRE) -- ARS Pharmaceuticals, Inc. (Nasdaq: SPRY), a biopharmaceutical company dedicated to empowering at-risk patients and their caregivers to better protect patients from allergic reactions that could lead to anaphylaxis, today announced the company will host a conference call and webcast on Monday, March 9, 2026 at 5:30 a.m. PT / 8:30 a.m. ET to discuss its fourth quarter and full year 2025 financial results and business highlights. Dial-in information for conference participants may be obtained by registering for the event.

BOSTON, Feb. 23, 2026 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage biotechnology company transforming the treatment of autoimmune diseases, today announced that it will be presenting and hosting 1x1 investor meetings at the 46th Annual TD Cowen Health Care Conference in Boston, MA.

Sylvamo's (NYSE: SLVM) board of directors declared a quarterly dividend of $0.45 per share for the period of April 1, 2026, to June 30, 2026. The dividend is payable April 28, 2026, to holders of record at the close of business April 7, 2026.

SAN DIEGO, Feb. 23, 2026 (GLOBE NEWSWIRE) -- LENZ Therapeutics, Inc. (Nasdaq: LENZ or “LENZ” or the “Company”), a pharmaceutical company focused on the commercialization of VIZZ® (aceclidine ophthalmologic solution) 1.44%, the first and only FDA-approved aceclidine-based eye drop for the treatment of presbyopia in adults, today announced that company management will participate in the following upcoming investor conferences:

KUALA LUMPUR, Malaysia, Feb. 23, 2026 (GLOBE NEWSWIRE) -- Alps Group Inc (the “Company” or “Alps Group”), the parent company of Alps Life Sciences Inc. (“Alps Holdco”), a fully integrated biotechnology research and healthcare platform specializing in predictive, preventive, and precision medicine, today announced a peer-reviewed case study in the February 2026 edition of SAGE Open Medical Case Reports.

Nationwide civic meeting data combines with parcel-level land intelligence providing visibility into how communities are responding to growth

Evercore (NYSE: EVR) announced today that Ben Hart has joined the firm as a senior managing director and head of its Asia Private Capital Advisory (PCA) division. Based in Singapore, Mr. Hart will oversee Evercore PCA’s activities across the Asia-Pacific region and work closely with the global PCA team to further expand the firm’s secondaries advisory and broader private markets capabilities in the region.

HOUSTON, Feb. 23, 2026 (GLOBE NEWSWIRE) -- LyondellBasell (NYSE:LYB) today announced updates to its 2030 climate and circularity goals amid the need for disciplined capital allocation, evolving market conditions and regulatory developments. The goals remain ambitious, while balancing the need to adjust for near-term achievability. The company’s three-pillared strategy remains unchanged: growing and upgrading the core, building a profitable circular and low-carbon business, and stepping up performance and culture. To ensure alignment with the strategy and reflect the realities of today’s operating environment, the updated goals are as follows:

Company also names Jared Vichengrad to lead Axonius Federal Systems; appointments mark the culmination of a strategic leadership expansion amidst record-breaking financial results

CERRITOS, Calif., Feb. 23, 2026 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (“TOI”) (NASDAQ: TOI), one of the largest value-based oncology groups in the United States, today announced the appointment of Kim Tzoumakas to its Board of Directors, effective February 23, 2026. Ms. Tzoumakas brings more than two decades of executive leadership experience across oncology, pharmacy services and healthcare operations. Notably, she is Chief Executive Officer for VytlOne National Pharmacy Services, and previously held the CEO role at 21st Century Oncology, where she successfully led the organization through a multi-year operational turnaround, culminating in its strategic sale. She also has served on the board of several private and public healthcare companies including SeaSpine, Coherus BioSciences, Ob Hospitalist Group and most recently, VytlOne.

ORANGE, Calif., Feb. 23, 2026 (GLOBE NEWSWIRE) -- Alignment Healthcare, Inc. (NASDAQ: ALHC), today announced that it will present at the Leerink Partners Global Healthcare Conference in Miami, Florida, on Tuesday, March 10, at 3:40 p.m. EST.

SOUTH SAN FRANCISCO, Calif., Feb. 23, 2026 (GLOBE NEWSWIRE) -- Lyell Immunopharma, Inc. (Nasdaq: LYEL), a clinical-stage company advancing a pipeline of next-generation chimeric antigen receptor (CAR) T-cell therapies for patients with cancer, today announced that members of its senior management team will present and participate in the following investor conferences:

DUBLIN and BRIDGEWATER, N.J., Feb. 23, 2026 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ: AMRN), a company committed to advancing the science of cardiovascular disease (CVD) worldwide, today issued a call to action for American Heart Month emphasizing a message that cannot wait: the United States has an opportunity to significantly reduce heart attacks, strokes, and cardiovascular deaths by prioritizing the use of proven, existing therapies that are widely available, yet significantly underutilized.

Live webcast of event on February 27 at 8:00 a.m. ET will include participation of globally renowned gynecological oncology KOLs from the US and EU

Joint team will complete preliminary design of the GEK1500 engine to meet high performance and aggressive cost targets, leveraging GEK800 maturation to accelerate delivery

WALTHAM, Mass., Feb. 23, 2026 (GLOBE NEWSWIRE) -- Sionna Therapeutics, Inc. (Nasdaq: SION), a clinical-stage biopharmaceutical company on a mission to revolutionize the current treatment paradigm for cystic fibrosis (CF) by developing novel medicines that normalize the function of the cystic fibrosis transmembrane conductance regulator (CFTR) protein, today announced that management will participate in fireside chats at the following upcoming investor events: